Maree Zinzley, Manager Approvals Operations, of the Ministry for Primary Industries (“MPI”), acting under delegated authority from the Director-General of MPI, gives notice under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”) that the following variation application has been made to a registered trade name product under section 9(2) of the Act:

Trade Name: Metacam 0.5mg/mL Oral Suspension for Cats

Reference: A009832-14

Active Ingredient and Concentration:

Meloxicam 0.5mg/mL

Formulation Type: Aqueous suspension

Current Claim:

Alleviation of inflammation and pain in acute and chronic musculo-skeletal disorders such as disco-spondylosis, arthopathy and soft tissue injuries in cats.

Proposed New Claims (changes in bold):

Alleviation of inflammation and pain in acute and chronic musculo-skeletal disorders such as disco-spondylosis, arthopathy and soft tissue injuries in cats. For the relief of post-operative pain associated with soft tissue surgery, such as castration, in guinea pigs.

Any person may make a written submission to the director-general concerning this application.

Under sections 16 and 17 of the Act, a written submission:

1. must state in full the reasons for making the submission;
2. may state any decision sought on that application; and
3. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.

The following address is:

1. where submissions on this application are to be sent;
2. where requests for copies of the public information relating to the application can be sent;
3. where public information relating to the application can be viewed; and
4. the director-general’s address for service:

ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.

The applicant’s address for service is:

Boehringer Ingelheim (NZ) Ltd, Level 3, 3 Osterley Way, Manukau, Auckland 2104. Postal Address: PO Box 76211, Manukau City, Auckland 2241.

Dated at Wellington this 16th day of October 2018.

MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).